Halozyme, Inc. has no current AI or cloud hiring signals in our index. Revenue growth: +38% YoY (annual revenue: $1.0B) — classified as 📈 High Growth per SEC 10-K filing. Publicly traded as HALO. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.
📊 Company Overview
📈 Financial Signals (SEC 10-K)
| Annual Revenue | $1.0B |
|---|---|
| Revenue Growth (YoY) | +37.6% |
| Growth Tier | 📈 High Growth |
Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →
📰 Recent News
Patents Court rejects MSD's bid for wider Mayne Pharma disclosure in Halozyme hyaluronidase dispute Solicitors Journal
Halozyme Can't Block MSD From Selling Cancer Jab In Europe Law360
Via Google News · Updated weekly
🎯 Outreach Strategy
Discovery questions based on Halozyme, Inc.’s signals — paste into your AI or CRM
“At +38% growth you're in high-growth mode. Is cloud capacity planning ahead of the business, or is infrastructure playing catch-up?”
☁️ Cloud Infrastructure
Behind Cloudflare — likely Azure or AWS (undetectable)
| Workspace | Microsoft 365 |
|---|---|
| CDN | Cloudflare |
Detected via DNS records and HTTP response headers as of 2026-07-20.
💰 Estimated Cloud Spend
🛠 Tech Stack & Marketing
| Ad Platforms | 🔒 Subscribers only |
|---|---|
| Analytics & CRM | 🔒 Subscribers only |
| CMS / Platform | WordPress |
| Frontend Stack | 🔒 Subscribers only |
Detected from Halozyme, Inc.'s public homepage as of 2026-07-20.
🔍 Compare with Similar Companies
Same sector (Professional Services), similar size
Data detected 2026-07-20 · Methodology · Suggest a correction